Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debora Fumagalli

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Plos One|September 1, 2018
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arraysVinu Jose, Debora Fumagalli, Françoise Rothé, et al.
BMC Cancer|April 18, 2015
No significant viral transcription detected in whole breast cancer transcriptomesDanai Fimereli, David Gacquer, Debora Fumagalli, et al.
Genes, Chromosomes & Cancer|February 14, 2018
Genomic hotspots but few recurrent fusion genes in breast cancerDanai Fimereli, Debora Fumagalli, David Brown, et al.
BMC Cancer|March 18, 2010
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodesDebora Fumagalli, Patrick G Gavin, Yusuke Taniyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Luminal B breast cancer: molecular characterization, clinical management, and future perspectivesFelipe Ades, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, et al.
Plos One|May 3, 2013
Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysisHatem A Azim, Sandeep Singhal, Michail Ignatiadis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Journal of the National Cancer Institute|June 7, 2013
Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancerSherene Loi, Stefan Michiels, Diether Lambrechts, et al.
The Lancet. Oncology|June 2, 2012
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpointsDebora Fumagalli, Philippe L Bedard, Zeina Nahleh, et al.
Breast Cancer Research : BCR|July 5, 2017
The footprint of the ageing stroma in older patients with breast cancerBarbara Brouwers, Debora Fumagalli, Sylvain Brohee, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Plos One|September 1, 2018
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arraysVinu Jose, Debora Fumagalli, Françoise Rothé, et al.
BMC Cancer|April 18, 2015
No significant viral transcription detected in whole breast cancer transcriptomesDanai Fimereli, David Gacquer, Debora Fumagalli, et al.
Genes, Chromosomes & Cancer|February 14, 2018
Genomic hotspots but few recurrent fusion genes in breast cancerDanai Fimereli, Debora Fumagalli, David Brown, et al.
BMC Cancer|March 18, 2010
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodesDebora Fumagalli, Patrick G Gavin, Yusuke Taniyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Luminal B breast cancer: molecular characterization, clinical management, and future perspectivesFelipe Ades, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, et al.
Plos One|May 3, 2013
Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysisHatem A Azim, Sandeep Singhal, Michail Ignatiadis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression DataIvana Bozovic-Spasojevic, Dimitrios Zardavas, Sylvain Brohée, et al.
Journal of the National Cancer Institute|June 7, 2013
Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancerSherene Loi, Stefan Michiels, Diether Lambrechts, et al.
The Lancet. Oncology|June 2, 2012
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpointsDebora Fumagalli, Philippe L Bedard, Zeina Nahleh, et al.
Breast Cancer Research : BCR|July 5, 2017
The footprint of the ageing stroma in older patients with breast cancerBarbara Brouwers, Debora Fumagalli, Sylvain Brohee, et al.
Pageof 7